文献速递糖尿病

瑞典30岁以下人群1型糖尿病发病率趋势及与SARS-CoV-2感染的关联

Trends in type 1 diabetes incidence between 2007 and 2023 and their association with SARS-CoV-2 infection in a population-based matched cohort study among individuals under 30 years old in Sweden.
PubMed 文献 · Diabetologia · 2025-09-18

基于瑞典30岁以下人群的匹配队列研究显示,2021年和2022年1型糖尿病发病率较疫情前趋势分别升高12%和9%,2023年回落至疫情前水平。SARS-CoV-2感染后整体1型糖尿病风险未增加(调整HR 0.96;95%CI 0.79,1.16),但5-10岁儿童感染后28天内风险升高(HR 2.68;95%CI 1.22,5.89)。

要点

  • 2021年1型糖尿病发病率较预测趋势升高12%(IRR 1.12;95%CI 1.06,1.19)。
  • 2022年发病率升高9%(IRR 1.09;95%CI 1.02,1.16),2023年回落至疫情前趋势。
  • SARS-CoV-2感染后整体1型糖尿病风险无显著增加(调整HR 0.96;95%CI 0.79,1.16)。

核心结论

  • 瑞典30岁以下人群1型糖尿病发病率在2021-2022年出现暂时性升高,2023年回落至疫情前趋势。
  • SARS-CoV-2感染与整体1型糖尿病风险增加无显著关联。
  • 5-10岁儿童感染后28天内1型糖尿病风险升高,但全随访期风险未增加。

研究设计与样本

  • 基于瑞典30岁以下全部注册个体的 population-based 匹配队列研究。
  • 采用Poisson回归评估2020-2023各年1型糖尿病发病率较2007-2019疫情前趋势的偏离。
  • 采用Cox比例风险模型评估SARS-CoV-2感染效应,感染者为病例,按出生年、性别和地区匹配5名对照。

主要发现

  • 2021年1型糖尿病发病率较预测线性趋势升高12%(IRR 1.12;95%CI 1.06,1.19)。
  • 2022年发病率升高9%(IRR 1.09;95%CI 1.02,1.16)。
  • 2023年发病率回落至疫情前趋势。
  • SARS-CoV-2感染后发生1型糖尿病的调整HR为0.96(95%CI 0.79,1.16)。
  • 5-10岁儿童感染后28天内发生1型糖尿病的HR为2.68(95%CI 1.22,5.89),但全随访期风险未增加。

临床怎么用

  • 应关注5-10岁儿童SARS-CoV-2感染后短期内的1型糖尿病风险,但整体风险未增加。
  • 瑞典疫情期1型糖尿病发病率升高仅部分与SARS-CoV-2感染相关,需探索其他环境与生活方式因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: The incidence of type 1 diabetes increased during the pandemic in various countries. SARS-CoV-2 infections may trigger the development of type 1 diabetes, but the evidence is inconclusive. This study aimed to assess trends in type 1 diabetes incidence between 2007 and 2023, and to quantify the association between SARS-CoV-2 infections and the risk for developing type 1 diabetes. METHODS: The study included all individuals under 30 years old registered in Sweden. Deviations in type 1 diabetes incidence from pre-pandemic trends (2007-2019) were assessed for each pandemic year (2020-2023) using Poisson regression. The effect of SARS-CoV-2 infections was assessed using Cox proportional hazards models in a cohort of infected individuals with five control individuals from the infection date of the case, matched by birth year, sex and region. RESULTS: Compared with the predicted linear trend, type 1 diabetes incidence increased by 12% during 2021 (incidence rate ratio [IRR] 1.12; 95% CI 1.06, 1.19) and 9% during 2022 (IRR 1.09; 95% CI 1.02, 1.16), but reverted to pre-pandemic trends in 2023. Overall, the adjusted HR for developing type 1 diabetes after SARS-CoV-2 infection was 0.96 (95% CI 0.79, 1.16). Children between 5 and 10 years old were more likely to develop type 1 diabetes within the first 28 days after infection (HR 2.68; 95% CI 1.22, 5.89), although their hazard over the whole follow-up period was not increased. CONCLUSIONS/INTERPRETATION: Sweden, with its non-restrictive pandemic response, saw a transient increase in type 1 diabetes incidence that was only partially associated with SARS-CoV-2 infections. Other explanations should be investigated, including environmental and lifestyle factors.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Dietler D, Björk J, Palmkvist E, et al. Trends in type 1 diabetes incidence between 2007 and 2023 and their association with SARS-CoV-2 infection in a population-based matched cohort study among individuals under 30 years old in Sweden. Diabetologia. 2025. PMID: 40968189. doi:10.1007/s00125-025-06540-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。